| Long non-coding RNAs associated with neurodegeneration-linked genes are reduced in Parkinson’s disease patients M Elkouris, G Kouroupi, A Vourvoukelis, N Papagiannakis, V Kaltezioti, ... Frontiers in cellular neuroscience 13, 58, 2019 | 80 | 2019 |
| Motor and nonmotor features of carriers of the p. A53T alpha‐synuclein mutation: a longitudinal study D Papadimitriou, R Antonelou, M Miligkos, M Maniati, N Papagiannakis, ... Movement Disorders 31 (8), 1226-1230, 2016 | 75 | 2016 |
| Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients N Papagiannakis, M Xilouri, C Koros, M Stamelou, R Antonelou, ... Movement Disorders 30 (13), 1830-1834, 2015 | 67 | 2015 |
| Circulating brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease S Ravanidis, A Bougea, N Papagiannakis, M Maniati, C Koros, AM Simitsi, ... Movement disorders 35 (3), 457-467, 2020 | 61 | 2020 |
| Differentially expressed circular RNAs in peripheral blood mononuclear cells of patients with Parkinson's disease S Ravanidis, A Bougea, D Karampatsi, N Papagiannakis, M Maniati, ... Movement Disorders 36 (5), 1170-1179, 2021 | 51 | 2021 |
| Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients S Ravanidis, A Bougea, N Papagiannakis, C Koros, AM Simitsi, I Pachi, ... Annals of clinical and translational neurology 7 (9), 1594-1607, 2020 | 51 | 2020 |
| Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease N Papagiannakis, C Koros, M Stamelou, AM Simitsi, M Maniati, ... Neuroscience letters 672, 145-149, 2018 | 51 | 2018 |
| Selective cognitive impairment and hyposmia in p.A53T SNCA PD vs typical PD C Koros, M Stamelou, A Simitsi, I Beratis, D Papadimitriou, ... Neurology 90 (10), e864-e869, 2018 | 30 | 2018 |
| Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson’s disease patients N Papagiannakis, M Xilouri, C Koros, AM Simitsi, M Stamelou, M Maniati, ... Neuroscience letters 704, 112-115, 2019 | 28 | 2019 |
| Frontotemporal dementia as the presenting phenotype of p. A53T mutation carriers in the alpha-synuclein gene A Bougea, C Koros, M Stamelou, A Simitsi, N Papagiannakis, ... Parkinsonism & Related Disorders 35, 82-87, 2017 | 28 | 2017 |
| The relationship between environmental factors and different Parkinson's disease subtypes in Greece: data analysis of the Hellenic Biobank of Parkinson's disease E Angelopoulou, M Bozi, AM Simitsi, C Koros, R Antonelou, ... Parkinsonism & related disorders 67, 105-112, 2019 | 24 | 2019 |
| Microcirculation-guided treatment improves tissue perfusion and hemodynamic coherence in surgical patients with septic shock A Chalkias, E Laou, M Mermiri, A Michou, N Ntalarizou, S Koutsona, ... European Journal of Trauma and Emergency Surgery 48 (6), 4699-4711, 2022 | 19 | 2022 |
| Sublingual microcirculatory alterations during the immediate and early postoperative period: A systematic review and meta-analysis A Chalkias, N Papagiannakis, G Mavrovounis, K Kolonia, M Mermiri, ... Clinical Hemorheology and Microcirculation 80 (3), 253-265, 2022 | 18 | 2022 |
| Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease E Emmanouilidou, N Papagiannakis, S Kouloulia, A Galaziou, ... Parkinsonism & Related Disorders 73, 35-40, 2020 | 17 | 2020 |
| Clinical practice recommendations on the management of perioperative cardiac arrest: a report from the PERIOPCA Consortium A Chalkias, N Mongardon, V Boboshko, V Cerny, AL Constant, ... Critical Care 25, 1-8, 2021 | 16 | 2021 |
| Phenotypic characteristics in GBA-associated Parkinson’s disease: A study in a Greek population A Simitsi, C Koros, M Moraitou, N Papagiannakis, R Antonellou, M Bozi, ... Journal of Parkinson's Disease 8 (1), 101-105, 2018 | 16 | 2018 |
| Circulating suPAR associates with severity and in‐hospital progression of COVID‐19 A Chalkias, A Skoulakis, N Papagiannakis, E Laou, K Tourlakopoulos, ... European journal of clinical investigation 52 (7), e13794, 2022 | 15 | 2022 |
| Serum uric acid level as a biomarker in idiopathic and genetic (p. A53T alpha-synuclein carriers) Parkinson’s disease: Data from the PPMI Study C Koros, AM Simitsi, D Papadimitriou, A Bougea, A Prentakis, ... Journal of Parkinson's Disease 10 (2), 481-487, 2020 | 15 | 2020 |
| Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study C Koros, AM Simitsi, N Papagiannakis, A Bougea, A Prentakis, ... Parkinsonism & Related Disorders 84, 1-4, 2021 | 13 | 2021 |
| Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease E Angelopoulou, M Bozi, AM Simitsi, C Koros, R Antonelou, ... Journal of the Neurological Sciences 442, 120405, 2022 | 12 | 2022 |
